Literature DB >> 27913509

The post-thrombotic syndrome.

Susan R Kahn1,2.   

Abstract

The post-thrombotic syndrome (PTS) is a frequent, sometimes disabling complication of deep vein thrombosis (DVT) that reduces quality of life and is costly. This article discusses risk factors for PTS after DVT and available means to prevent and treat PTS, with a focus on new information in the field. After DVT, PTS will develop in 20% to 50% of patients, and severe PTS, including venous ulcers, will develop in 5% to 10%. The principal risk factors for PTS are anatomically extensive DVT, recurrent ipsilateral DVT, persistent leg symptoms 1 month after acute DVT, obesity, and older age. By preventing the initial DVT and ipsilateral DVT recurrence, primary and secondary prophylaxes of DVT will prevent cases of PTS. Based on recent evidence from a large multicenter trial, routine use of elastic compression stockings (ECS) after DVT to prevent PTS is not advocated, but in patients with DVT-related leg swelling that is bothersome, a trial of ECS is reasonable. Selecting DVT patients for catheter-directed thrombolytic treatment as a means of preventing PTS should be done on a case-by-case basis, with a focus on patients with extensive thrombosis, recent symptoms onset, and low bleeding risk. For patients with established PTS, daily use of ECS may help to relieve symptoms and edema. Intermittent compression devices can be tried in patients with moderate-to-severe PTS whose symptoms are inadequately controlled with ECS alone. A supervised exercise training program may improve PTS symptoms. Management of post-thrombotic ulcers should ideally involve a multidisciplinary approach. Important areas for future research are summarized.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27913509      PMCID: PMC6142466          DOI: 10.1182/asheducation-2016.1.413

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  43 in total

Review 1.  Definition of post-thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations.

Authors:  N A Goldenberg; L R Brandão; J Journeycake; S R Kahn; P Monagle; S Revel-vilk; A Sharathkumar; A K C Chan
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

Review 2.  Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials.

Authors:  Jacqueline M Cohen; Elie A Akl; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  How to predict and diagnose postthrombotic syndrome.

Authors:  Anat Rabinovich; Susan R Kahn
Journal:  Pol Arch Med Wewn       Date:  2014-05-23

4.  Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel.

Authors:  Suresh Vedantham; Susan R Kahn; Samuel Z Goldhaber; Anthony J Comerota; Sameer Parpia; Sreelatha Meleth; Diane Earp; Rick Williams; Akhilesh K Sista; William Marston; Suman Rathbun; Elizabeth A Magnuson; Mahmood K Razavi; Michael R Jaff; Clive Kearon
Journal:  Vasc Med       Date:  2016-05-30       Impact factor: 3.239

Review 5.  Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review.

Authors:  Vighnesh Bharath; Susan R Kahn; Alejandro Lazo-Langner
Journal:  Blood       Date:  2014-07-08       Impact factor: 22.113

6.  Postthrombotic vein wall remodeling: preliminary observations.

Authors:  Kristopher B Deatrick; Megan Elfline; Nichole Baker; Catherine E Luke; Susan Blackburn; Catherine Stabler; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2010-09-24       Impact factor: 4.268

7.  Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.

Authors:  Susan R Kahn; Stan Shapiro; Philip S Wells; Marc A Rodger; Michael J Kovacs; David R Anderson; Vicky Tagalakis; Adrielle H Houweling; Thierry Ducruet; Christina Holcroft; Mira Johri; Susan Solymoss; Marie-José Miron; Erik Yeo; Reginald Smith; Sam Schulman; Jeannine Kassis; Clive Kearon; Isabelle Chagnon; Turnly Wong; Christine Demers; Rajendar Hanmiah; Scott Kaatz; Rita Selby; Suman Rathbun; Sylvie Desmarais; Lucie Opatrny; Thomas L Ortel; Jeffrey S Ginsberg
Journal:  Lancet       Date:  2013-12-06       Impact factor: 79.321

Review 8.  Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.

Authors:  Russell D Hull; Jane Liang; Grace Townshend
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

9.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Susan R Kahn; Jim Julian; Elizabeth Magnuson; Michael R Jaff; Timothy P Murphy; David J Cohen; Anthony J Comerota; Heather L Gornik; Mahmood K Razavi; Lawrence Lewis; Clive Kearon
Journal:  Am Heart J       Date:  2013-03-05       Impact factor: 4.749

Review 10.  Valvular dysfunction and venous obstruction in the post-thrombotic syndrome.

Authors:  Suresh Vedantham
Journal:  Thromb Res       Date:  2009       Impact factor: 3.944

View more
  27 in total

1.  Compression therapy for treating post-thrombotic syndrome.

Authors:  Sara Azirar; Diebrecht Appelen; Martin H Prins; Martino Ham Neumann; Adriaan Np de Feiter; Dinanda N Kolbach
Journal:  Cochrane Database Syst Rev       Date:  2019-09-18

Review 2.  Evaluation and Management of Chronic Venous Disease Using the Foundation of CEAP.

Authors:  Teresa L Carman; Ali Al-Omari
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

3.  External validation of Villalta score in high-middle income country patients with deep vein thrombosis.

Authors:  Rafael Bernardes de Ávila; Giulianna Barreira Marcondes; Silfayner Victor Mathias Dias; Beatriz Périco da Silveira; Jorge Eduardo de Amorim; Henrique Jorge Guedes Neto; Luis Carlos Uta Nakano; Ronald Luiz Gomes Flumignan
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

4.  Percutaneous endovenous intervention versus anticoagulation in the treatment of lower extremity deep vein thrombosis: a systematic review and meta-analysis.

Authors:  Guofu Hu; Jian Wang
Journal:  Ann Transl Med       Date:  2022-09

Review 5.  Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review.

Authors:  Ke Xuan Li; Gisele Diendéré; Jean-Philippe Galanaud; Nada Mahjoub; Susan R Kahn
Journal:  Res Pract Thromb Haemost       Date:  2021-05-08

Review 6.  Management of Lower Extremity Pain from Chronic Venous Insufficiency: A Comprehensive Review.

Authors:  Vwaire Orhurhu; Robert Chu; Katherine Xie; Ghislain N Kamanyi; Bisola Salisu; Mariam Salisu-Orhurhu; Ivan Urits; Rachel J Kaye; Jamal Hasoon; Omar Viswanath; Aaron J Kaye; Jay Karri; Zwade Marshall; Alan D Kaye; Dua Anahita
Journal:  Cardiol Ther       Date:  2021-03-11

7.  Combination of Circulating miRNA-320a/b and D-Dimer Improves Diagnostic Accuracy in Deep Vein Thrombosis Patients.

Authors:  Zhiyun Jiang; Junfen Ma; Qian Wang; Fan Wu; Jiedan Ping; Liang Ming
Journal:  Med Sci Monit       Date:  2018-04-06

8.  Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.

Authors:  Chase W Kessinger; Guanming Qi; Malek Z O Hassan; Peter K Henke; Ahmed Tawakol; Farouc A Jaffer
Journal:  Circ Cardiovasc Imaging       Date:  2021-03-16       Impact factor: 7.792

Review 9.  Circulating microRNA expression and their target genes in deep vein thrombosis: A systematic review and bioinformatics analysis.

Authors:  Zhiyun Jiang; Junfen Ma; Qian Wang; Fan Wu; Jiedan Ping; Liang Ming
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Development of a core outcome set for studies on prevention and management of pregnancy-associated venous thromboembolism (COSPVenTE): a study protocol.

Authors:  Alexandria King; Rohan D'Souza; Lizabeth Teshler; Nadine Shehata; Ann K Malinowski
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.